The article announces major revisions to the physician labeling for prescription drugs proposed by the U.S. Food and Drug Administration (FDA). The revisions aim to provide better information on the effects of medicines used during pregnancy and breastfeeding. They will give health care professionals information for prescribing decisions and counseling women who are pregnant or breastfeeding. Significant information on the use of medicines during pregnancy is also outlined.
Processing Request
No Comments.